US baby formula manufacturer Perrigo has struck a deal to expand the distribution of its products in China.
Perrigo formula will be distributed by Founder Pharma, a subsidiary of Chinese pharmaceutical group Southwest Synthetic.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Joseph Papa, Perrigo’s Perrigo chairman and CEO, said today (19 October): “Southwest Synthetic is an exciting partner given its strong reputation and healthcare focus. Perrigo’s high quality products and Southwest Synthetic’s strong brand, marketing, and distribution should be a winning combination in the world’s most robust infant formula market.”
Perrigo produces own-label pharmaceutical products and infant formula. Southwest Synthetic manufactures, develops and exports pharmaceuticals and is located in the Chinese city of Chongqing.